Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome (original) (raw)
Conter V, Arico M, Valsecchi MG, Basso G, Biondi A, Madon E et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies. Leukemia 2000; 14: 2196–2204. ArticleCASPubMed Google Scholar
Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia. Leukemia 2000; 14: 2307–2320. ArticleCASPubMed Google Scholar
Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia 2000; 14: 2223–2233. ArticleCASPubMed Google Scholar
Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000; 14: 2267–2275. ArticleCASPubMed Google Scholar
Harms DO, Janka-Schaub GE . Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 2000; 14: 2234–2239. ArticleCASPubMed Google Scholar
Kamps WA, Veerman AJ, van Wering ER, van Weerden JF, Slater R, van der Does-van den Berg A . Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia. Leukemia 2000; 14: 2240–2246. ArticleCASPubMed Google Scholar
Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA . Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1983–1994. Leukemia 2000; 14: 2276–2285. ArticleCASPubMed Google Scholar
Pui C-H, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000; 14: 2286–2294. ArticleCASPubMed Google Scholar
Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin–Frankfurt–Munster. Leukemia 2000; 14: 2205–2222. ArticleCASPubMed Google Scholar
Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD et al. Results of DANA-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995). Leukemia 2000; 14: 2247–2256. ArticleCASPubMed Google Scholar
Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K et al. Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981–1995. Leukemia 2000; 14: 2295–2306. ArticleCASPubMed Google Scholar
Vilmer E, Suciu S, Ferster A, Bertrand Y, Cave H, Thyss A et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 2000; 14: 2257–2266. ArticleCASPubMed Google Scholar
Pui C-H, Frankel SL, Carroll AJ, Ramondi SC, Shuster JJ, Head DR et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 1991; 77: 440–447. CASPubMed Google Scholar
Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11). A report of the Children's Cancer Group. Leukemia 1999; 13: 679–686. ArticleCASPubMed Google Scholar
Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur D, Lange B et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527–535. ArticleCASPubMed Google Scholar
Hunger SP . Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211–1224. CASPubMed Google Scholar
Third International Workshop on Chromosomes in Leukemia, 1980 (1981): Clinical significance of chromosomal abnormalities in acute lymphoblasic leukemia. Cancer Genet Cytogenet 1981; 4: 111–137.
Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F . Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933–4937. CASPubMed Google Scholar
Shurtleff SA, Buijs A, Behm FG, Raimondi SC, Hancock ML, Chan GC-F et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989. CASPubMed Google Scholar
Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999; 94: 4036–4046. CASPubMed Google Scholar
Uckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG et al. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leuk Lymph 1999; 345: 998–1006. Google Scholar
Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R et al. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients entrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia 1996; 10: 957–963. CASPubMed Google Scholar
Christ W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990; 76: 489–494. Google Scholar
Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV . Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 1991; 5: 196–199. CASPubMed Google Scholar
Thomas X, Danaila C, Le QH, Sebban C, Troncy J, Charrin C et al. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period. Leukemia 2001; 15: 1811–1822. ArticleCASPubMed Google Scholar
Maurer J, Janssen JW, Theil E, van Denderen J, Ludwig WD, Aydemir U et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058. ArticleCASPubMed Google Scholar
Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F et al. Clinical significance of the BCR-ABL fusion gene in adult lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood 1992; 80: 1983–1990. Google Scholar
Chissoe SL, Bodenteich A, Wang YW, Wang YP, Burian D, Clifton SW et al. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 1995; 27: 67–82. ArticleCASPubMed Google Scholar
Pane F, Figeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414. CASPubMed Google Scholar
Arico M, Valsecchi MG, Camitta B, Scrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998–1006. ArticleCASPubMed Google Scholar
Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18–24. ArticleCASPubMed Google Scholar
Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G . Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 1986; 14: 191–194. ArticleCASPubMed Google Scholar
Rieder H, Ludwig WD, Gassmann W, Maurer J, Janssen JW, Gokbuget N et al. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol 1996; 95: 678–691. ArticleCASPubMed Google Scholar
Mitelman F (ed). ISCN (1995): An International System for Human Cytogenetic Nomenclature. Karger S. Basel. Google Scholar
Russo C, Carroll A, Kohler S, Borowitz M, Amylon M, Homans A et al. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1991; 77: 1050–1056. CASPubMed Google Scholar
Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481. Article Google Scholar
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. Br J Cancer 1977; 35: 1–39. ArticleCASPubMedPubMed Central Google Scholar
Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170. CASPubMed Google Scholar
Heerema N, Sather H, Sensel M, Liu-Mares W, Lange B, Bostrom B et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999; 94: 1537–1544. CASPubMed Google Scholar
Murphy SB, Raimondi SC, Rivera GK, Crone M, Dodge RK, Behm FG et al. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood 1989; 74: 409–415. CASPubMed Google Scholar
Zhou M, Gu L, Yeager AM, Findley HW . Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1997; 14: 141–150. ArticleCASPubMed Google Scholar
Diccianni MB, Batova A, Yu J, Vu T, Pullen J, Amylon M et al. Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Leuk Res 1997; 21: 549–558. ArticleCASPubMed Google Scholar
Kees UR, Burton PT, Lu C, Baker DL . Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcomes. Blood 1997; 89: 4161–4166. CASPubMed Google Scholar
Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 1992; 10: 606–613. ArticleCASPubMed Google Scholar
Bloomfield CD, Secker-Walker LM, Goldman AI, Van Den Berghe H, de la Chapelle A, Ruutu T et al. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40: 171–185. ArticleCASPubMed Google Scholar
Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 2000; 18: 1876–1887. ArticleCASPubMed Google Scholar
Harris M, Shuster J, Carroll A, Look A, Borowitz M, Crist W et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992; 79: 3316–3324. CASPubMed Google Scholar
Nanjangud G, Kadam PR, Saikia T, Bhisey A, Kumar A, Gopal R et al. Karyotypic findings as an independent prognostic marker in chronic myeloid leukemia blast crisis. Leuk Res 1994; 18: 385–392. ArticleCASPubMed Google Scholar
Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR et al, for the United Kingdom Medical Research Council's Childhood Leukaemia Working Party. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003; 102: 2756–2762. ArticleCASPubMed Google Scholar
Huntly BJP, Bench A, Green AR . Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003; 102: 1160–1168. ArticleCASPubMed Google Scholar
Johansson B, Mertens F, Mitelman F . Primary vs secondary neoplasia-associated chromosomal abnormalities – balanced rearrangements vs genomic imbalances? Genes Chromosomes Cancer 1996; 16: 155–163. ArticleCASPubMed Google Scholar